ClinConnect ClinConnect Logo
Search / Trial NCT05372159

Vanderbilt Memory and Aging Project

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · May 11, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Alzheimer's Disease Biomarkers Brain Mri Cardiac Mri Mild Cognitive Impairment Vascular Risk Factors Longitudinal Studies

ClinConnect Summary

The Vanderbilt Memory and Aging Project is a research study aimed at understanding how vascular health (the health of blood vessels) relates to early signs of Alzheimer’s disease and other brain health issues in older adults. The study will involve observing a group of 1,000 adults aged 50 and older, some of whom may have mild memory problems, while others will be cognitively healthy. Researchers will look at various factors, including brain scans and biological markers, to see how vascular health may impact brain aging and the development of cognitive issues.

To be eligible to participate, you should be 50 years or older and speak English. About 150 participants will have mild cognitive impairment, meaning they have some memory or thinking difficulties but can still carry out daily activities. The study excludes individuals with certain medical conditions, such as serious heart problems or neurological disorders, as these can affect brain function. Participants can expect to undergo tests and brain scans (like MRIs) as part of the study. Overall, this research aims to uncover important information about how keeping our blood vessels healthy might help preserve brain function as we age.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants recruited will include 1,000 adults age 50 and older.
  • After the eligibility visit, a small portion of participants (\~150) enrolling must meet diagnostic criteria for mild cognitive impairment according to a clinician diagnosis and/or medical records (i.e., participants must have mild memory or cognitive problems, but they must be free of any functional problems and not have Alzheimer's disease or another form of dementia). The remaining \~850 participants will be cognitively unimpaired adults age 50 and older.
  • Because the neuropsychological tests used to measure cognitive performance are validated on English-speaking populations, we require that English be the primary language of all participants.
  • Exclusion Criteria:
  • No available reliable study partner
  • History of major psychiatric illness (e.g., schizophrenia, bipolar), neurological illness (e.g., stroke, epilepsy, multiple sclerosis, Parkinson's disease, dementia), or head injury with significant loss of consciousness. These exclusion criteria have been applied because they affect brain structure and function.
  • Diagnosis of congestive heart failure
  • Diagnosis of atrial fibrillation or other heart arrhythmia
  • Diagnosis of Chronic obstructive pulmonary disease
  • Diagnosis of cancer (current)
  • History of serious alcohol or drug abuse (past or current)
  • Participants unable to undergo MRI will be excluded. Reasons may include: a. Subjects who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.). b. Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced. c. Subjects who have cerebral aneurysm clips. d. Subjects who may have shrapnel imbedded in their bodies (e.g., from war wounds), metal workers and machinists (e.g., potential for metallic fragments in or near the eyes). e. Subjects who are pregnant. Given that the minimum age of recruitment for the current study is 50 years of age, it is unlikely that prospective participants will be excluded because of pregnancy. f. Subjects who have excessive amounts of metal dental work based on records released by their dentist.

About Vanderbilt University Medical Center

Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.

Locations

Nashville, Tennessee, United States

Patients applied

0 patients applied

Trial Officials

Angela Jefferson, PhD

Principal Investigator

Vanderbilt University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials